Li, Xiaoming <br/><br/>
Effect of noncompetitive proteasome inhibition on bortezomib resistance.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jul 2010 
 - 1069-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djq198  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacokinetics<br/>Apoptosis--drug effects<br/>Boronic Acids--pharmacokinetics<br/>Bortezomib<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Hydroxyquinolines--pharmacokinetics<br/>Immunoblotting<br/>Inhibitory Concentration 50<br/>Male<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Multiple Myeloma--drug therapy<br/>NF-kappa B--metabolism<br/>Protease Inhibitors--pharmacology<br/>Proteasome Inhibitors<br/>Pyrazines--pharmacokinetics<br/>Transplantation, Heterologous